BF
ALNY icon

BOK Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

BOK Financial’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.6K Sell
148
-194
-57% -$58.5K ﹤0.01% 851
2026
Q1 		$113K Buy
+342
New +$116K ﹤0.01% 742
2025
Q2 		– Sell
-52
Closed -$14K – 1153
2025
Q1 		$14K Sell
52
-329
-86% -$84.6K ﹤0.01% 956
2024
Q4 		$90.7K Buy
381
+326
+593% +$85.7K ﹤0.01% 759
2024
Q3 		$14.8K Sell
55
-5,696
-99% -$1.48M ﹤0.01% 952
2024
Q2 		$1.4M Sell
5,751
-961
-14% -$152K 0.03% 420
2024
Q1 		$1.03M Buy
6,712
+1,295
+24% +$216K 0.02% 475
2023
Q4 		$1.04M Sell
5,417
-1,305
-19% -$222K 0.02% 452
2023
Q3 		$1.02M Buy
6,722
+1,706
+34% +$325K 0.02% 433
2023
Q2 		$953K Sell
5,016
-149
-3% -$29.5K 0.02% 467
2023
Q1 		$1.03M Sell
5,165
-492
-9% -$103K 0.02% 451
2022
Q4 		$1.34M Sell
5,657
-2,350
-29% -$501K 0.02% 446
2022
Q3 		$1.6M Sell
8,007
-875
-10% -$167K 0.03% 402
2022
Q2 		$1.3M Buy
+8,882
New +$1.26M 0.02% 463
2020
Q3 		– Sell
-6,094
Closed -$903K – 855
2020
Q2 		$903K Buy
+6,094
New +$822K 0.02% 480
2015
Q2 		– Sell
-12,051
Closed -$1.26M – 858
2015
Q1 		$1.26M Buy
+12,051
New +$1.22M 0.04% 400

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BOK Financial's ALNY Position: Q2 2026 in Review

BOK Financial reduced its Alnylam Pharmaceuticals (ALNY) stake by 57% in Q2 2026, selling an estimated $58.5K and leaving 148 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #851.

BOK Financial first reported a position in ALNY in Q1 2015 and has held it in 16 quarters since. The position peaked at $1.6M in Q3 2022. 784 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • BOK Financial held 148 shares of Alnylam Pharmaceuticals worth $44.6K as of Q2 2026.
  • BOK Financial sold 194 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $58.5K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #851 holding.
  • BOK Financial first reported a position in Alnylam Pharmaceuticals in Q1 2015 and has held it in 16 quarters since.
  • BOK Financial's Alnylam Pharmaceuticals position peaked at $1.6M in Q3 2022.
  • 784 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.